CCND1 and colorectal carcinoma: Previously, we have demonstrated that indomethacin treatment of SW480 human CRC cells is associated with decreased expression of the β-catenin/TCF target gene cyclin D1 (Smith et al, 2000; Hawcroft et al, 2002).